Incannex Healthcare (IXHL) Interest Expenses (2023 - 2026)

Incannex Healthcare (IXHL) posted quarterly Interest Expenses of $123000.0 for Q1 2026, down 61.32% year-on-year from $318000.0 in Q1 2025, and down 30.11% on a QoQ basis from $176000.0 in Q4 2025.

Incannex Healthcare (IXHL) Interest Expenses (2023 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Interest Expenses for 4 consecutive years, with $123000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Interest Expenses fell 61.32% year-over-year to $123000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123000.0 (down 61.32% YoY) and the FY2025 annual result came in at $303000.0, down 99.82% from the prior year.
  • Interest Expenses fell to $123000.0 in Q1 2026 per IXHL's latest filing, from $176000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for IXHL reached as high as $171.9 million in Q2 2024 and fell as low as $123000.0 in Q1 2026.
  • A 4-year average of $15.9 million and a median of $363000.0 in 2024 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2024 — Interest Expenses surged 115254.36% — and 2026, when it tumbled 61.32%.
  • Year by year, Interest Expenses stood at $609000.0 in 2023, then sank by 40.39% to $363000.0 in 2024, then plunged by 51.52% to $176000.0 in 2025, then tumbled by 30.11% to $123000.0 in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods registered $123000.0, $176000.0, and $227000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 944.51 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.77 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 2.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.21 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 590.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Incannex Healthcare 3.63 Mn 3.63 Mn - 123,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 123,000.00
Mar 31, 2026 123,000.00
Dec 31, 2025 176,000.00
Dec 31, 2025 176,000.00
Sep 30, 2025 227,000.00
Sep 30, 2025 227,000.00
Mar 31, 2025 318,000.00
Mar 31, 2025 318,000.00
Dec 31, 2024 363,000.00
Dec 31, 2024 363,000.00
Sep 30, 2024 458,000.00
Sep 30, 2024 458,000.00
Jun 30, 2024 171.88 Mn
Jun 30, 2024 171.88 Mn
Mar 31, 2024 534,000.00
Mar 31, 2024 534,000.00
Dec 31, 2023 609,000.00
Dec 31, 2023 609,000.00
Sep 30, 2023 442,000.00
Sep 30, 2023 442,000.00